Jan 29, 2021
By Jane Brown
Another COVID-19 vaccine candidate has emerged.
The makers at Novavax Inc. say it appears about 89 per cent effective overall in early results from a British Study.
Company scientists say it also seems to work, although not quite as well, on the new mutated versions of COVID-19 which originated in the United Kingdom and South Africa.
The study of the Novavax candidate involving 15,000 people in Britain continues, but an interim analysis finds the vaccine is 96 per cent effective against the original new coronavirus and nearly 86 per cent effective against the new U.K. variant.
Novavax scientists are waiting for additional data before seeking British approval for the vaccine’s use which they expect to have sometime next month.